Search

Search Constraints

You searched for: Author/Creator Bowman, Simon J

Search Results

1. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts. Issue 1 (26th October 2016)

2. A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome. (19th September 2020)

3. A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years. Issue 6 (12th November 2012)

5. Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study. (March 2020)

6. B-cell activity markers are associated with different disease activity domains in primary Sjögren's syndrome. (28th March 2018)

8. Classification criteria for Sjögren's syndrome: we actually need to definitively resolve the long debate on the issue. Issue 4 (22nd December 2012)

9. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Issue 2 (5th December 2014)

10. Development and preliminary validation of the Sjögren's Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren's syndrome. Issue 7 (7th April 2022)